The validity of using the mini mental state examination in NICE dementia guidelines [4]

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 2, 2004, Pages 343-344

  Davey, R J ^a   Jamieson, S ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR;

AGED; ALZHEIMER DISEASE; CLINICAL PRACTICE; DEMENTIA; HEALTH SURVEY; HUMAN; LETTER; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; REPRODUCIBILITY; UNITED KINGDOM;

AGED; DEMENTIA; HUMANS; NEUROPSYCHOLOGICAL TESTS; REPRODUCIBILITY OF RESULTS;

EID: 0842287593     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2003.018432     Document Type: Letter

References (4)

1. Folstein MF, Folstein SE, McHugh PR. Mini mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
2. National Institute for Clinical Excellence. Guidance on the use of donepezil, rivastigmine and galantamine for the treatment of Alzheimer's disease. London: NICE, 2001; http:// www.nice.org.uk/pdf/ALZHEIMER_full_ guidance.pdf.
3. Rogers SL, Doody RS, Mohs RC, et al. Donepezil improves cognition and global function in Alzheimer's disease: a 15-week, double-blind, placebo-controlled study. Arch Intern Med 1998;158:1021-31.
4. Bowie P, Branton T, Holmes J. Should the mini mental state examination be used to monitor dementia treatments? Lancet 1999;354:1527-8.